Publication:


abstract

BACKGROUND:

autoimmune hepatitis (AIH) is a non-resolving inflammatory liver disease. Inflammation showing plasma cells under hematoxylin-eosin (H&E) stain is typical of AIH. In many cases, however, only lymphocytes and occasional granulocytes are found. It was recently noticed that the antibody to multiple myeloma oncogene 1/IRF4 (MUM1), stained plasma cells and their precursors.

PATIENTS AND METHODS:

Liver biopsies from 11 patients were stained with H&E and with anti-MUM1. Clinically, four patients were suspicious of AIH, four had viral hepatitis C, two nonalcoholic steatohepatitis (NASH) and one, fatty liver. Counting was performed in three high-power fields.

RESULTS:

In patients having clinical suspicion of AIH, H&E revealed plasma cells in only one of the four cases. On the other hand, MUM1 immunostain revealed such cells in all four cases, MUM1-expressing cells were found in the portal triads, in the zone corresponding to interface inflammation and in the parenchyma surrounding the interface hepatitis. MUM 1-expressing cells ranged from 26 to 44 in AIH, from 2 to 15 in viral hepatitis C, from 1 to 3 in NASH, and from 0 to 2 in the case with fatty liver (AIH vs. viral hepatitis C/NAS/fatty liver, p<0.05).

CONCLUSION:

These preliminary results suggest that MUM1 immunostain may be of help in endorsing a presumptive clinical diagnosis of AIH and may add valuable information in the differential diagnosis between AIH and the other liver diseases examined here. This appears to be the first report in which MUM1 immunostain has been applied to assess the presence of plasma cell precursors in AIH.

Related Articles
The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury.
Hepatology. 2011
The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury.
Suzuki A, Brunt EM, Kleiner DE, Miquel R, Smyrk TC, Andrade RJ, Lucena MI, Castiella A, Lindor K, Björnsson E. Hepatology. 2011 Sep 2; 54(3):931-9. Epub 2011 Aug 8.
Autoimmune hepatitis with centrilobular necrosis.
Am J Surg Pathol. 2004
Autoimmune hepatitis with centrilobular necrosis.
Misdraji J, Thiim M, Graeme-Cook FM. Am J Surg Pathol. 2004 Apr; 28(4):471-8.
Review Re-analysis of clinical features of 89 patients with autoimmune hepatitis using the revised scoring system proposed by the International Autoimmune Hepatitis Group.
Intern Med. 2000
Review Re-analysis of clinical features of 89 patients with autoimmune hepatitis using the revised scoring system proposed by the International Autoimmune Hepatitis Group.
Omagari K, Masuda J, Kato Y, Nakata K, Kanematsu T, Kusumoto Y, Mori I, Furukawa R, Tanioka H, Tajima H, et al. Intern Med. 2000 Dec; 39(12):1008-12.
The revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis/overlap syndromes and autoimmune hepatitis with concurrent other liver disorders.
J Autoimmune Dis. 2007
The revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis/overlap syndromes and autoimmune hepatitis with concurrent other liver disorders.
Papamichalis PA, Zachou K, Koukoulis GK, Veloni A, Karacosta EG, Kypri L, Mamaloudis I, Gabeta S, Rigopoulou EI, Lohse AW, et al. J Autoimmune Dis. 2007 Jun 29; 4:3. Epub 2007 Jun 29.
Review Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood.
Minerva Gastroenterol Dietol. ...
Review Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood.
Maggiore G, Riva S, Sciveres M. Minerva Gastroenterol Dietol. 2009 Mar; 55(1):53-70.